Clinical trial
Prospective Evaluation of Cannabidiol (CBD) on Anxiety: A Pilot Study
NCT04267679 is registered in ClinicalTrials.gov with CB2 Insights as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of Cannabidiol (CBD) on Anxiety: A Pilot Study
- Lead sponsor
- CB2 Insights
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- March 1, 2020
- Completion date
- December 1, 2020
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety